re: Ann: MAK: Third Supplementary Target'... Not convinced they have anything to gain by attacking, per the first article. Seriously risks tipping the balance in the middle east against them - they have a fragile accord as it is with neoghbouring states.
I can't see the MAK statement as an attempt to gain Mehdiabad - they have indicated previously it's not of much interest to them. I read it as an attempt to win the moral highground on reasonability and thus try and force UCL to make their next move. It presents most reasonably, which may be part of the strategy, however UCL should only move when ready. Certainly that will at least in part require waiting for Takeover Panel Review decision which may be in the next week given approval for the review was over a week ago now.
I'm expecting a revision of the bid shortly after that decision is made and so we wait.
- Forums
- ASX - By Stock
- Ann: Third Supplementary Target's Statement
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.8¢ |
Change
-0.001(11.1%) |
Mkt cap ! $25.42M |
Open | High | Low | Value | Volume |
0.9¢ | 0.9¢ | 0.8¢ | $3.935K | 437.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 7234999 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 202000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 7234999 | 0.008 |
5 | 3147490 | 0.007 |
5 | 2585000 | 0.006 |
2 | 1300000 | 0.005 |
2 | 1450000 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 202000 | 2 |
0.010 | 6540823 | 13 |
0.011 | 1100099 | 2 |
0.012 | 2544954 | 2 |
0.013 | 1234269 | 4 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
AEV (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online